5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.51▼ | 1.50▲ | 1.49▲ | 1.41▲ | 1.32▲ |
MA10 | 1.50▼ | 1.49▲ | 1.49▲ | 1.34▲ | 1.35▲ |
MA20 | 1.49▲ | 1.47▲ | 1.47▲ | 1.30▲ | 1.30▲ |
MA50 | 1.47▲ | 1.42▲ | 1.38▲ | 1.31▲ | 2.83▼ |
MA100 | 1.45▲ | 1.37▲ | 1.31▲ | 1.28▲ | 4.69▼ |
MA200 | 1.38▲ | 1.30▲ | 1.41▲ | 1.93▼ | 6.15▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.000▼ | 0.000▲ | 0.024▲ | 0.144▲ |
RSI | 51.837▲ | 58.678▲ | 59.539▲ | 57.931▲ | 45.360▼ |
STOCH | 65.615 | 54.365 | 77.341 | 62.966 | 26.975 |
WILL %R | -35.714 | -35.714 | -13.889▲ | -18.182▲ | -66.628 |
CCI | 18.620 | 106.287▲ | 67.560 | 161.875▲ | 64.489 |
Tuesday, April 29, 2025 09:26 PM
SAN DIEGO, April 30, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM).
|
Tuesday, April 29, 2025 09:26 PM
SAN DIEGO, April 30, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM).
|
Monday, April 28, 2025 07:45 PM
ATNM investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.51 | 1.54 | 1.4301 | 1.49 | 317,965 |
30/04/25 | 1.43 | 1.52 | 1.345 | 1.52 | 517,300 |
29/04/25 | 1.33 | 1.57 | 1.31 | 1.44 | 808,220 |
28/04/25 | 1.34 | 1.43 | 1.25 | 1.30 | 552,400 |
25/04/25 | 1.23 | 1.36 | 1.2105 | 1.31 | 321,407 |
24/04/25 | 1.30 | 1.40 | 1.26 | 1.27 | 339,400 |
23/04/25 | 1.40 | 1.45 | 1.27 | 1.30 | 320,372 |
22/04/25 | 1.25 | 1.39 | 1.23 | 1.38 | 578,400 |
21/04/25 | 1.18 | 1.21 | 1.165 | 1.20 | 259,500 |
17/04/25 | 1.23 | 1.2399 | 1.17 | 1.21 | 323,482 |
|
|
||||
|
|
||||
|
|